ReadyTech Holdings (ASX:RDY) secures its role as the Student Management System (SMS) platform provider for the Victorian TAFE Network, positioning the company as a long-term technology partner for one of Australia`s largest vocational education systems.

🎓 Victorian TAFE Network role secured: Following a competitive tender process, ReadyTech will provide the common SMS platform for Victoria`s network of 11 TAFE institutes. The agreement has an initial five-year term, with implementation to be progressed through future negotiations with individual TAFE institutes.
🤝 Building on established partnerships: The role expands ReadyTech`s existing relationships with Bendigo Kangan Institute, Chisholm Institute and Melbourne Polytechnic. The platform has been developed through a multi-year co-design process to support modern TAFE delivery and the growing convergence of vocational and higher education.
📚 Positioned for future digital transformation: While no revenue has been contracted and rollout timelines are yet to be determined, the agreement positions ReadyTech to support more than 170,000 TAFE students annually across Victoria as the network considers future implementation and digital transformation initiatives.

"This selection validates our long-term investment in an enterprise-grade education platform capable of supporting system-level transformation. What began as a co-designed partnership with Bendigo Kangan Institute has evolved into a platform now recognised as fit to support the future of the Victorian TAFE Network, and we are proud to be trusted as a long-term technology partner in this important work." – Marc Washbourne, ReadyTech Holdings CEO & Co-Founder

There`s a global memory chip shortage right now and it’s been dubbed, “RAMageddon”. Every device needs memory chips called RAM to work and RAM was more affordable until AI arrived and demand exploded. Now every AI company is racing to build data centres and those data centres are ravenous for memory.

As a result memory chip prices have more than tripled from their lows, as the big makers pour everything into AI and starve the consumer market. And now it`s hitting your wallet. Apple Inc (NASDAQ:AAPL) just raised Mac and iPad prices, blaming memory costs, followed by Microsoft Corp’s (NASDAQ:MSFT) Xbox getting more expensive for the same reason.

AI might be the future. But right now, it`s a tax on the present and that’s why it’s been called RAMageddon.

#tech #AI #apple #nasdaq #fintok

It’s the first day of the new financial year, is the ASX poised to keep rising? - That depends on where you look. Over the last year the ASX 200 barely rose, lifting just 2.8%.

Looking more closely, FY26 was a divided year on the ASX. The best-performing sector, Materials, rose almost 50% on the back of a comeback in gold, lithium and rare earths.

Healthcare and Info Tech sectors both crashed nearly 40%. FY26 is a reminder that even on one exchange, in one year, it`s never really one market.

#EOFY #ASX #stocks #mining #health

Neuren Pharmaceuticals (ASX: NEU) moved a step closer to expanding the reach of its Rett syndrome treatment, with the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommending approval of DAYBU® (trofinetide) in the European Union.

💊 Positive EU recommendation for DAYBU®: The CHMP has adopted a positive opinion recommending European Commission marketing authorisation for DAYBU® to treat neurobehavioral symptoms of Rett syndrome in adults and children aged five years and older. If approved, it would become the first treatment for this indication in the European Union.
🌍 Commercial milestone opportunity: Under its licensing agreement with Acadia Pharmaceuticals, Neuren would receive US$35 million following the first commercial sale of DAYBU® in Europe, along with tiered royalties on net sales and potential milestone payments of up to US$170 million based on future sales thresholds.
🧠 Expanding treatment access: The European Commission is expected to make a final decision in the coming months. If authorised, the approval would cover all 27 European Union member states, as well as Iceland, Liechtenstein and Norway, expanding access to treatment for people living with Rett syndrome.

"With no approved treatment currently available in the EU, approval of DAYBU® would represent an important step forward for patients, caregivers and the wider Rett syndrome community profoundly impacted by this devastating condition." – Jon Pilcher, Neuren Pharmaceuticals CEO

Nickel Industries (ASX:NIC) has just announced two significant transactions, both strengthening its position in Indonesia`s nickel industry and increasing its exposure to the EV battery supply chain. Nickel Industries has acquired stakes in the CNE and TMI HPAL projects, securing additional Class 1 nickel production while maintaining a disciplined approach to growth. Importantly, the Sampala Project remains central to the strategy, with the resource identified as the exclusive ore supplier to both CNE and TMI. As Nickel Industries positions to become an even larger player in the battery materials market Managing Director Justin Werner joins Lel Smits from The Stock Network to discuss the rationale behind the transactions and key catalysts to watch next.

🇮🇩 Importance of recently announced deals in Indonesia
⚒️ Unlocking the value of the Sampala Project
🚀 Future catalysts and milestones

As market volatility and diversification become bigger considerations for investors, many are rethinking the traditional approach of picking individual blue chip stocks and instead turning to ETFs for broader exposure and portfolio simplicity. In this Women in ETFs ETF Education Spotlight, The Stock Network’s Lel Smits is joined by Sacha Burchgart Founder & Managing Director of Burcheart, to discuss why ETFs are gaining traction among investors, the challenges of stock picking, and how investors can think about balancing both strategies in modern portfolios.

📈 Why investors are shifting to ETFs
🎯 The challenges of stock picking
🛡️ Diversification and risk management
💙 Can blue chip stocks still outperform?
⚖️ Building a balanced portfolio

The ASX just put every listed company on notice because of a trick called “share ramping” - it’s when companies release a stream of ASX market announcements that sound exciting to lift their share price, but are light on substance.

In its first-ever supervision report, the ASX said it will target companies that repeatedly use announcements to inflate their price. This all matters because investors rely on ASX announcements to make decisions, and not every flashy headline reflects real progress.

The crackdown is designed to restore trust by ensuring market updates inform investors, rather than influence them.

#ASX #stocks #fintok #money #investing

Artificial intelligence is creating some of the world`s fastest-growing and most valuable companies, but many of the biggest opportunities remain private and inaccessible to most investors. AI Private Opportunities Trust (ASX:AIX) is listing on the ASX this Thursday after having raised over $265 million and will be focused on providing Australian investors with exposure to leading private AI companies through a market-first ASX-listed investment vehicle. Pengana Capital Group Executive Director Adam Myers speaks with The Stock Network`s Lel Smits about the growing AI investment opportunity, why investors may be structurally under-exposed to private AI, and how AIX aims to provide access to this rapidly evolving sector.

🤖 The AI opportunity on ASX
🌐 Investing across the AI ecosystem
🚀 The AIX difference